Ultragenyx Pharmaceutical Long-Term Investments 2012-2024 | RARE
Ultragenyx Pharmaceutical long-term investments for the quarter ending June 30, 2024 were $0.111B, a 54.07% increase year-over-year.
- Ultragenyx Pharmaceutical long-term investments for 2023 were $0.2B, a 34.19% increase from 2022.
- Ultragenyx Pharmaceutical long-term investments for 2022 were $0.149B, a 49.31% decline from 2021.
- Ultragenyx Pharmaceutical long-term investments for 2021 were $0.294B, a 77.15% increase from 2020.